Sislab Plus is a laboratory management platform from Orbsis Tech for clinical testing, pathology, and research laboratories. It is positioned as an integrated LIS solution covering the full workflow from patient registration and test routing to report delivery. The official website emphasizes automation, accuracy, traceability, and security, and explicitly states compatibility with SIA-SUS, HL7/FHIR, laboratory analyzers, and AWS cloud environments.
The product’s core capabilities cover test management, triage, status tracking, digital reports, PDF generation, email delivery, dashboards, and business reports. Bidirectional analyzer integration is a key strength, helping reduce manual transcription and analytical errors. On the billing side, it supports automated SUS billing and can export BPA files according to SIA/SUS standards. The Enterprise plan also includes centralized multi-institution management, HL7/FHIR, and open APIs, making it suitable for more complex hospital or laboratory chain interoperability scenarios.
The official website lists three tiers—Starter, Professional, and Enterprise—but all require a custom quote. Starter is aimed at small laboratories with up to 300 tests per day, Professional targets laboratories with up to 1,000 tests and multiple departments, while Enterprise is designed for networks and hospitals with unlimited test volume. For deployment, the page mentions Cloud AWS, and Enterprise can choose either on-premises or cloud deployment. The implementation process is fairly comprehensive, including requirements analysis, configuration, data migration, system integration, online/offline training, and ongoing support. Support hours are Monday to Friday 07:00–18:00 and Saturday 07:00–12:00.
Its strengths are its relatively complete coverage of core laboratory workflows, especially for Brazilian laboratories that need analyzer integration, SUS billing, HL7/FHIR connectivity, and multi-institution management. Its implementation and training services are also clearly described. The downsides are that pricing is not transparent, and there is no disclosed free version or self-service trial. The patient portal is shown as coming soon, while details on permissions, auditing, API documentation, and security are not fully public.
It is better suited to local Brazilian clinical testing organizations, pathology laboratories, hospital laboratories, and lab chains. Because it is closely tied to Brazilian local compliance and payment systems such as SUS, SIA/SUS, and LGPD, Chinese organizations may face relatively high adaptation costs if adopting it directly. The official website does not specify access conditions from China or supported payment methods. Before purchasing, it is advisable to test network connectivity and first compare domestic LIS options, HIS/LIS integrators, and alternative medical laboratory information systems in China.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on orbsis.com.br official site.
orbsis.com.br is an Brazil SaaS Tools provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach orbsis.com.br directly.